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INTRODUCTION
CD8 T cells play a key role in tumor immunosurveillance and clearing
of intracellular infectious agents, and a subset of them known as cytotoxic
T lymphocytes (CTLs) are capable of directly killing infected and tumor
cells.1 CTLs discriminate between normal and damaged cells using their
T cell receptor (TCR) to monitor the peptides presented by major histo-
compatibility class I (MHCI) molecules on the cell surface. T cells recog-
nizing self-peptides are eliminated during the process of thymic selection,
and, thereby, T cell immune responses are triggered by the recognition of
MHC molecules incorporating foreign or antigenic peptides (T cell epi-
topes).2 T cell epitopes result from the degradation of proteins through
pathways that determine the repertoire of peptides that are available for
binding to MHC and recognition by T cells. The dominant pathway for
class I antigen processing is reviewed next.
MHCI molecules preferably bind peptides nine residues long that gener-
ally originate from endogenous proteins that are degraded in the cytosol
of the cell by the proteolytic activity of the proteasome.3,4 Peptide frag-
ments cleaved by proteasomes are shuttled to the lumen of the endoplas-
mic reticulum (ER) by the transporter associated with antigen processing
(TAP), where they can bind to newly assembling MHCI molecules.5,6
Before MHCI binding, peptides can also undergo an optional N-terminal
trimming by ER-associated amino peptidases (ERAAP).7 Finally, peptide-
MHCI complexes are exported to the cell surface for presentation to the
CD8 T cells.5,6 There is evidence supporting that these processing steps
limit/shape the peptides that can be presented by MHCI molecules in
vivo,7-9 thus explaining the numerous observations of high affinity MHCI
binding peptides that are unable to elicit CTL responses.10,11 Nonetheless,
peptide transport by TAP represents the single most selective step in T cell
epitope processing.12 In addition, TAP is also important for presentation
of epitopes derived from exogenous antigens.13
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ABSTRACT
The transport of peptides to the endoplas-
mic reticulum by the transporter associ-
ated with antigen processing (TAP) is a
necessary step towards determining CD8 T
cell epitopes. In this work, we have studied
the predictive performance of support vec-
tor machine models trained on single resi-
due positions and residue combinations
drawn from a large dataset consisting of
613 nonamer peptides of known affinity to
TAP. Predictive performance of these TAP
affinity models was evaluated under
10-fold cross-validation experiments and
measured using Pearson’s correlation coef-
ficients (Rp). Our results show that every
peptide position (P1–P9) contributes to
TAP binding (minimum Rp of 0.26 6 0.11
was achieved by a model trained on the P6
residue), although the largest contributions
to binding correspond to the C-terminal
end (Rp 5 0.68 6 0.06) and the P1 (Rp 5
0.51 6 0.09) and P2 (0.57 6 0.08) residues
of the peptide. Training the models on
additional peptide residues generally
improved their predictive performance and
a maximum correlation (Rp 5 0.89 6 0.03)
was achieved by a model trained on the
full-length sequences or a residue selection
consisting of the first 5 N- and last 3 C-
terminal residues of the peptides included
in the training set. A system for predicting
the binding affinity of peptides to TAP
using the methods described here is readily
available for free public use at http://
imed.med.ucm.es/Tools/tapreg/.
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TAP belongs to the ATP-dependent binding cassette
(ABC) transporter superfamily, and it is expressed as a
heterodimer consisting of the TAP1 and TAP2 proteins
subunits.14,15 Both TAP1 and TAP2 proteins encode one
hydrophobic transmembrane domain and one ATP bind-
ing domain. Transport of peptides by TAP proceeds in
two sequential steps, where peptide binding to TAP
occurs first followed by a translocation step consuming
ATP.16-18 Peptide transport rate by TAP is governed by
the initial binding step.19,20 Likewise, TAP preselection
of peptides available for MHCI presentation is also con-
trolled by their affinity to TAP. Selectivity of TAP has
been studied from data generated using assays that deter-
mine peptide binding to TAP or peptide accumulation in
the ER.17,18 TAP preferentially transports peptides with
a length of 8–16 residues,14,21 whereas longer peptides
may be transported but with much lower efficiency.
Besides peptide length preferences, the first three N-ter-
minal residues and the C-terminal end of the peptides
have also been shown to be important for binding to
TAP.12,22 Furthermore, a peptide-binding motif for TAP
has been defined by van Endert et al.,22 which indicates
a TAP preference for hydrophobic aromatic residues at
the C-terminus, hydrophobic residues at position 3 (P3),
and charged and hydrophobic residues at position 2
(P2). On the other end, aromatic or acidic residues at P1
and prolines at P1 and P2 have strong deleterious effects.
A number of methods have also been applied for pre-
dicting and analyzing the binding affinity of peptides to
TAP, such as artificial neural networks,23-25 support vector
machines (SVMs),26,27 and matrices generated using the
Stabilized Matrix Method28 and the additive method.29,30
The majority of these methods were trained on the same
training set of 435 nonamer (9-mer) peptides of known
affinity to TAP made available by Dr. van Endert, and until
now their performance has not been compared in an inde-
pendent testing set. In contrast, here we have used a much
larger training set, encompassing 178 new peptides, to ana-
lyze TAP binding preferences using SVMs. Interestingly,
our results indicate that each peptide residue has a signifi-
cant contribution to TAP binding. Moreover, we have gen-
erated TAP binding affinity models that in cross-validation
experiments achieved a correlation between experimental
and predicted values of 0.89  0.03, which is stronger than
that of related methods. Based on these results, we have
implemented a system, TAPREG, for predicting affinity of
peptides to TAP that is available for free public use at
http://imed.med.ucm.es/Tools/tapreg/.
MATERIAL ANDMETHODS
Peptide datasets
The main dataset used in this study to analyze the
peptide selectivity of TAP consisted of 613 unique
nonamer (9-mer) peptides of known binding affinity
to human TAP relative to the reference peptide RRYNASTEL
(IC50relative). The lower the IC50relative, the stronger the
peptide binds to TAP. This dataset encompasses 435 pep-
tides, kindly provided by Dr. Peter van Endert23
(INSERM U580, Paris Descartes University, Paris,
France)—IC50relative already referenced to RRYNASTEL—
plus 178 peptides parsed from the TAP binding affinity
peptide collection of the Antijen Database,31 kindly pro-
vided by Dr. Darren Flower (The Jenner Institute, Comp-
ton, UK). To combine the peptides into a single dataset,
the TAP binding affinity (IC50) of peptides collected
from the Antigen Database was also referenced to the
peptide RRYNASTEL. For peptides obtained from the
Antigen Database that were identical in sequence but had
different TAP binding affinities, median values were
considered before referencing. This dataset is provided as
Supporting Information in Table 1S. We thank to
Dr. Peter van Endert and Dr. Darren Flower for showing
no inconvenience in that we provided Table 1S as Sup-
porting Information.
Peptide datasets with reduced sequence similarity were
generated from the 613-peptide dataset using the purge
utility of the Gibbs Sampler32 with an exhaustive method
and maximum blosum 62 relatedness scores of 25, 30, 35,
and 37. The resulting datasets had 293, 332, 465, and 530
peptides and are provided as Supporting Information (Ta-
ble 2S, Table 3S, Table 4S, and Table 5S, respectively).
To compare TAP affinity scores predicted by available
methods, we used a set of 723 unique 9-mer CD8 T cell
epitopes obtained from the IMMUNEEPITOPE33 and
EPIMHC34 databases (provided as Supporting Informa-
tion in Table 6S).
Model building and evaluation
Predictive models of TAP affinity were trained and
evaluated under the EXPERIMETER application of the
Waikato Environment for Knowledge Analysis (WEKA)
package.35 WEKA provides a framework for data classifi-
cation, clustering, and feature selection using a large col-
lection of machine-learning algorithms. In this study, we
have selected kernel-based SVMs. Specifically, we used a
radial basis function (RBF) as the kernel in combination
with Alex Smola and Bernhard Scholkopf ’s sequential
minimal optimization algorithm for training SVMs
(SMOreg algorithm in WEKA).36,37 Model refinement
was achieved by varying the C (0.2, 0.4, 0.8, 1, 2, 4, 8,
10) and gamma (0.001, 0.0025, 0.005, 0.01, 0.025, 0.05,
0.1, 0.2, 0.3, 0.4, 0.5) values of the RBF kernel. Predictive
models were generated from distinct training sets, con-
sisting of different residue selections drawn from the
peptide sequences of the training set and encoded using
sparse and blosum representations. In the sparse encod-
ing, each amino acid is coded by the relevant amino acid
symbol, whereas in the blosum encoding, it is repre-
sented by 20 digits corresponding to the relevant amino
C.M. Diez-Rivero et al.
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acid substitution scores given by the BLOSUM62 substi-
tution matrix.38 TAP affinity (IC50relative) values of the
training sets were provided to WEKA as logIC50relative val-
ues. Pearson’s correlation coefficient (Rp) was used to
measure the performance of SVMs to fit the experimental
data. Since SVM models were built and evaluated using
10-fold cross-validation experiments that were repeated
10 times, Rp mean values and standard deviations were
computed from 100 different values. Predicted
peptide affinity scores yielded by the models generated
with WEKA were transformed to IC50 values by consi-
dering an IC50 for the reference peptide RRYNASTEL of
400 nM.
Sequence similarity analyses
Sequence similarity in peptide datasets was analyzed
from pairwise sequence alignments between all peptides
in the dataset. Sequence alignments were obtained using
the Needleman-Wunsch global alignment algorithm
implemented with the needle application that is included
in the EMBOSS package.39 Alignments with peptide
positions shifted were not evaluated (e.g., residues 1–4 of
a peptide aligned with residues 3–7 of another peptide).
Generally, for any given peptide (query) in the dataset,
one could find several peptides that shared sequence sim-
ilarity with it (hits), but the majority of the peptides in
the dataset had no similarity with the query. In this
study, we have computed average sequence similarities in
the peptide datasets in two ways: globally, considering all
possible pairwise comparisons between the peptide
sequences but those with themselves (for a dataset with
N peptides there will be N 3 N-1 comparisons), and
using only the hits.
For a given query peptide in the dataset, the relation-
ship between sequence similarity and binding affinity was
studied by correlating sequence similarity with hits and
differences in binding affinity (logIC50relative) using Spear-
man’s rank correlation (Rs). For instance, let us consider
the peptide PLAKAAAAV (logIC50relative 5 8.370) had the
following hits:
Hit:ALAKAAAAV; Identity:88.9%; Similarity:88.9%;
logIC50relative:3.984; Dif:4.386
Hit:ALAKAAAAL; Identity:77.8%; Similarity:88.9%;
logIC50relative:0.688; Dif:7.682
Hit:AAASAAAAF; Identity:66.7%; Similarity:77.8%;
logIC50relative:20.734; Dif:9.104
Hit:ALAKAAAAF; Identity:55.6%; Similarity:66.7%;
logIC50relative:0.332; Dif:8.038
Hit:GRQKGAGSV; Identity:33.3%; Similarity:44.4%;
logIC50relative:6.215; Dif:2.155
Then, for peptide PLAKAAAAV, an Rs value was com-
puted by correlating the similarity/identity with its pep-
tide hits (88.9, 77.8, 66.7, 55.6, 33.3) and the differences
in logIC50relative values (4.386, 7.682, 9.104, 8.038, 2.155).
Rs values were thus computed for each peptide in the
dataset. Peptides with less than five hits were discarded
from this analysis. These peptide-specific Rs values were
determined considering all peptide hits and only those
with an identity  50%.
Statistical analyses
To assess whether the correlation achieved by a given
SVM model, i, during training was stronger than that of
another SVM model, j, we used one-sided two-sample
t-test to examine if the differences of the relevant Rp
mean values were significantly above 0 (Ho: Rpi – Rpj 5
0; P  0.05). To evaluate if Rp values were statistically
significant (H0: Rp 5 0), we computed the statistics given
by Eq. (1), which follows a t-Student distribution with
N – 2 degrees of freedom, and tested subsequently
(P < 0.05).
t ¼ Rpffiffiffiffiffiffiffiffiffiffi
1Rp2
N2
q ð1Þ
To evaluate the correlation coefficients obtaining by
comparing the TAP affinity scores predicted by different
methods with each other or with experimental data, we
applied the test for comparing overlapping correlation
coefficients described by Meng et al.,40 as implemented
in the R package compOverlapCorr by Ka-Lon Li (http://
cran.us.r-project.org/web/packages/compOverlapCorr/
index.html). Briefly, Fisher’s Z-transform is applied first
to the relevant correlation coefficients (Ri) using Eq. (2).
Zi ¼ 1
2
ln
1þ Ri
1 Ri
8>: 9>; ð2Þ
Next, a statistics Z, which follows a normal distribu-
tion is computed using Eq. (3), and tested subsequently
(P < 0.05).
Z ¼ ðzi  zjÞ
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
N  3
2ð1 RijÞh
s
ð3Þ
In Eq. (3), Rij is the correlation between the predicted
values by the methods i and j being compared, and h 5
(1 2 f R2)/(1 2 R2), with R2 5 (R2i 1 R
2
j)/2 and f 5
(1 2 Rij)/2(1 2 R
2).
Web server implementation
The TAPREG Web server for predicting the binding af-
finity of peptides to TAP was implemented on an Apache
Web server under the Mac OSX operating system. The
TAPREG core consists of a PERL CGI (Common Gate-
way Interface) script that executes the predictions on
Reliable Prediction of PBA to TAP
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user-provided input data and returns the results to the
browser. In addition, the TAPREG web interface uses
JavaScript for handling and verification of input data
before submission.
RESULTS
Quantitative analysis of TAP selectivity
using TAP affinity models
We have approached the study of TAP selectivity using
a large dataset consisting of 613 9-mer peptides (DS613)
of known affinity to TAP (logIC50relative) and SVMs
under a regression schema. SVMs are among the most
widely used methods for solving common data mining
problems in bioinformatics41-43 and were chosen
because of their solid theoretical foundations and proven
generalization ability.44 A key feature of SVMs is the use
of nonlinear functions (kernels) to map the input onto a
higher dimensional space in which an optimal separation
is achieved—in the regression task—using a linear regres-
sion conducted with an e-insensitive loss function for
error minimization.44 In this study, we have selected
RBF kernels (Material and Methods) because in prelimi-
nary training experiments they outperformed the alterna-
tive linear and polynomial kernels (data not shown).
Moreover, we have chosen two peptide sequence repre-
sentations, sparse and blosum (Material and Methods),
as input for SVMs. The evolutionary relationships
between amino acids are taken into consideration with
blosum representations of peptide sequences, which may
enhance the generalization power of the resulting models.
Using WEKA as the framework for model building and
parameter optimization (Material and Methods), we first
evaluated the ability of SVM models to predict TAP
affinity data when trained on individual peptide residues
(P1–P9), judging from the relevant Pearson’s correlation
coefficient (Rp). No differences were observed for models
generated on blosum or sparse encoded sequences. Inter-
estingly, for each peptide residue position, it was possible
to generate SVM models that fitted the data with Rp val-
ues [Fig. 1(A)] that are significant for a linear correlation
(P  0.05, Material and Methods). The lowest correlation
was obtained with a model trained on the P6 residue (Rp
of 0.26  0.11), whereas the largest correlation corre-
sponded to a model trained on the C-terminal end of
the peptide (Rp 5 0.68  0.06) followed by the models
trained on the P2 (0.56  0.08) and the P1 (Rp 5 0.51
 0.09) residues of the peptide. Systematic pairwise com-
parisons between the predictive performance of the dif-
ferent position-specific TAP affinity models using one-
side t-tests over the relevant Rp means (Material and
Methods) showed the following peptide residue position
relevance to TAP binding: (P6 5 P5) < (P8 5 P7) 
(P3 5 P4)  P1  P2  P9 (C-terminal end).
To evaluate the contribution of several peptide residues
to TAP binding and to improve the correlation results,
SVMs were trained on peptide fragments consisting of
residue combinations drawn from the peptides of the
training set. A total of 20 SVM models were generated
Figure 1
Performance of TAP-affinity prediction models. Models were trained using SVM and their performance was measured using Rp values between
predictions and experimental values determined under 10-fold cross-validation experiments that were repeated 10 times. Thus, Rp mean values and
standard deviations obtained over 100 measures are represented in the figure. Moreover, plotted Rp values were those achieved by SVMs after
parameter optimization. (A) Performance of models trained on individual residues of the 9-mer peptides (1–9) included in the training set. (B)
Performance of models trained on different peptide fragments consisting of the first i N-terminal and the last j C-terminal residues of the peptides
in the training set. Residue selections, iNjC are indicated in the abscissa. Grey bars are for SVM models trained on sparse sequence representations
and black bars for models trained using blosum sequence representations. There was no difference between sparse and blosum trained models on
single peptide residues. Data for making these representations—including the relevant RBF parameters of SVMs—are provided as Supporting
Informtion in Table 7S.
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and named after the specific peptide residue selection
used for training (model iNjC was generated from a frag-
ment of i 1 j residues, consisting of the first i N-termi-
nal and last j C-terminal residues of the peptides of the
training set). Rp values achieved by these models on the
training set together with those achieved by the models
trained on just the C-terminus and the full-length pep-
tide sequences (9-mers) are shown in Figure 1(B). Few
or no differences were observed between SVMs trained
using different sequence representations: sparse [gray
bars in Fig. 1(B)] and blosum [black bars in Fig. 1(B)].
However, when differences were found, correlations
obtained with the models trained on sparse encoded
sequences were always larger than their blosum counter-
parts and were significantly stronger (P  0.05) for mod-
els 3N2C, 4N1C, 4N2C, 5N2C, 4N3C, 4N4C, 3N5C,
5N3C, and ALL (trained on the full-length sequences).
Several other general features emerged upon a detailed
analysis of these results. Increasing the number of
selected residues in the training sets (drawn from the
peptides of known affinity to TAP) significantly
improved the correlations achieved by the models
[Fig. 2(A)], which went from an Rp value of 0.68  0.06
for a model trained on just the C-terminal end of the
peptides of the training set to an Rp of 0.89  0.03 for
the model trained on the full-length sequences (non-
amers). Interestingly, a model trained on just eight resi-
dues (5N3C) achieved the same or better correlation (for
blosum encoding) than models trained on the full-length
peptide sequences [Figs. 1(B) and 2]. Nevertheless, for
each fragment size, the best correlations were obtained
with models trained on fragments encompassing more
N-terminal than C-terminal peptide residue selections
(2N1C, 3N1C, 4N2C, 4N3C, and 5N3C) [Fig. 2(A)], and
these correlations were significantly stronger (P  0.05)
than those obtained with models with reversed N-termi-
nal and C-terminal residue selections (1N2C, 1N3C,
2N4C, 3N4C, and 3N5C) [Fig. 2(B)]. This observation
supports a larger contribution of the N-terminal half of
the peptide to TAP binding when compared with its
C-terminal half.
Sequence similarity in peptide datasets and
predictive performance of SVMmodels
To explore the predictive performance of SVM models
in relation to the sequence similarity between testing and
training sets, we generated four peptide datasets of 293,
332, 465, and 530 peptides (DS293, DS332, DS465, DS530,
respectively) by discarding similar sequences from the
original DS613 dataset (Material and Methods). The
global sequence identity in percentage in these datasets
varied from 1  6% in the DS293 dataset to 9  23% in
the DS530 dataset, whereas in the DS613 dataset it was 10
 25% (Table I). In the 435-peptide dataset provided by
Peter van Endert (PVE435) the global identity is 5 
16%. The overall low sequence similarity in the datasets
reflects that the peptides do not belong to a single class
or group related by a given property. On the contrary,
each peptide is linked to a different numeric value (logI-
C50relative). The average number of similarity hits per pep-
tide in the datasets varied from nine peptides in the
DS293 dataset to 110 hits in the DS613 dataset (Table I).
Sequence identity between hits was considerably larger
Figure 2
Analysis of TAP selectivity using TAP-affinity prediction models. SVM-Models trained using sparse sequence representation were selected. (A)
Predictive performance (Rp) of SVM-models with regard to the fragment size used for training (1–9). Only the largest Rp value achieved by a
specific model (indicated in the abscissa) at each fragment size is represented. Statistically significant increments between Rp values of neighboring
models are indicated with a ‘‘*’’ symbol. (B) Predictive performance of the best SVM-models generated upon optimal first i N- and last j C-
terminal residue selections (gray bars) compared with those generated from suboptimal first j N- and last i C-terminal residue selections (black
bars). Statistically significant differences were found between Rp values in all cases (indicated with a ‘‘*’’ symbol). Statistical significance was assessed
using t-tests (Material and Methods).
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and ranged from 23% in the DS293 dataset to 59% in the
DS613 dataset (Table I).
Because we train and evaluate the predictive perform-
ance of SMVs using 10-fold cross-validation experiments,
and we repeat these experiments 10 times. we can assume
that sequence similarity between testing and training sets
to be comparable to that in the entire datasets. The
correlation between predictions and experimental
logIC50relative values achieved by SVMs trained and eval-
uated on the datasets of reduced sequence similarity
(DS293, DS332, DS465, DS530, and PVE435) was signifi-
cantly lower (P  0.05; one-sided t-tests) than that
obtained in the DS613 dataset (Table I). The smallest Rp
was achieved in the DS293 dataset (0.71  0.1), and these
values increased significantly (P  0.05) as the number of
peptides in the datasets (Table I). Thus, DS613Rp > DS530Rp
> DS465Rp > PVE435Rp > DS332Rp > DS293Rp.
These results may apparently suggest that prediction
rates by our SVM models became inflated as sequence
similarity in the datasets increased. However, this is an
unlikely scenario because Rp values were computed in
cross-validation, and the differences in Rp that we
observed were statistically significant. For sequence simi-
larity to be responsible for inflating prediction rates, the
larger the sequence similarity between peptides in the
datasets the closer their binding affinity must be. As a
result, for any given peptide in the dataset one would
expect to find a negative correlation between the similar-
ity to its peptide hits and the differences in binding affin-
ity (Material and Methods for details). However, we have
not found such a negative correlation for the vast major-
ity of the peptides in any of the datasets, as shown in the
boxplot depicted in Figure 3. On the contrary, we have
found these correlations to be shifted toward positives
values; correlation medians in the DS293, DS332, DS465,
DS613, and PVE435 datasets were 0.083, 0.109, 0.102,
0.139, 0.1945, and 0.114, respectively. Notably, the
median of the correlation values in the DS613 dataset is
significantly larger than those of the remaining datasets
(P  0.05), as judged from Wilcoxon-Mann-Whitney tests.
Virtually identical results were obtained when only hits
with  50% identity were considered (data not shown).
These results indicate that sequence similarity between
peptides in the datasets does not correlate with proximity
in binding affinity—in fact the opposite would appear to
be the case. Therefore, the prediction rates obtained with
SVMs trained on DS613 dataset are not inflated due to
sequence similarity redundancy. Furthermore, similar
sequences in the DS613 dataset are not redundant and
contribute to the appropriated modeling of TAP binding
affinity by SVMs; hence, the enhanced prediction rates
achieved by models trained on the DS613 dataset.
Comparison of methods for predicting
binding affinity of peptides to TAP
We have compared our SVM model trained on 9-mer
peptide sequences that achieved an Rp 5 0.89  0.03
(hereafter TAP613) with four alternative predictive
Table I
Predictive Performance of SVMs Trained on Datasets with Different Sequence Similarity
Dataset Rp Identity (%)
a Similarity (%)a Identity (%)b Similarity (%)b Hitsc
DS293 0.71  0.1 1  6 2  10 23  11 43  11 9  7
DS332 0.76  0.09 2  8 3  11 28  18 46  14 14  12
DS465 0.85  0.05 7  19 8  21 52  25 60  19 59  45
DS530 0.87  0.03 9  23 10  25 57  24 62  26 86  62
DS613 0.89  0.03 10  25 11  26 59  23 66  18 110  77
PVE435 0.83  0.05 5  16 6  18 45  26 56  19 40  33
aIdentity and similarity computed considering all possible pairwise comparisons between the peptides in the datasets.
bIdentity and similarity computed considering only hits (Material and Methods).
cAverage number of similarity hits per peptide in the dataset.
Figure 3
Relationship between sequence similarity in peptide datasets and
binding affinity proximity. This figure depicts a boxplot of Rs values
computed for each peptide in a dataset by correlating their identity
with its hits and the difference in logIC50relative values (Material and
Methods). Boxplot were generated for peptides in DS293, DS332, DS465,
DS530, DS613, and PVE435 datasets. Median Rs values in peptide datasets
are indicated with a cross. A negative Rs will indicate that the larger the
sequence similarity between peptides the closer their binding affinity.
Conversely, a positive correlation will reflect that the larger the sequence
similarity between peptides the larger the difference in their binding
affinity.
C.M. Diez-Rivero et al.
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methods of peptide binding affinity to TAP, which are
readily available from the relevant publications (those by
Peters et al.28 and Doytchinova et al.29) or from dedi-
cated Web services (TAPPRED26 and SVMTAP27). The
method developed by Doytchinova et al.29 consists of a
matrix generated from 163 poly-Alanine 9-mer peptides
of known affinity to TAP using an additive method30;
hence, we will refer to this method as ADM. The ADM
method achieved a reported Rp between 0.72 and 0.83,
depending of the testing set.29 The remaining methods
have been trained on the PVE435 dataset.28 Briefly,
Peters’ et al.28 method is based on a consensus matrix
(CM) that was obtained from three scoring matrices,
which included a poly-Alanine derived matrix and a
SMM-matrix (generated using the Stabilized Matrix
Method) trained on the PVE435 dataset. The CM method
achieved a reported Rp of 0.782 on the PVE435 dataset.
The TAPPRED26 and SVMTAP27 methods are based on
SVMs trained solely on the PVE435 dataset and achieved
reported Rp of 0.82 and 0.88, respectively. The TAPPRED
method is based on two layers of SVMs, whereas
SVMTAP consists of a single SVM model, similar to
those trained in this study. We have evaluated all these
methods in a testing set consisting of the 178 peptides of
known affinity to TAP collected in this study (DS178),
using Spearman’s correlation coefficients (Rs) (Table II).
Interestingly, the lowest Rs values were achieved by
TAPPRED and SVMTAP (0.67 and 0.61), the methods
with the largest reported correlations. On the other hand,
CM achieved an Rs (0.87) comparable to the value
achieved by our TAP613 model in cross-validation (0.89),
and AMD achieved an intermediate Rs value of 0.74. Sta-
tistical comparison of these Rs values (Material and
Methods) indicated that the correlations obtained with
the CM and TAP613 methods were significantly stronger
than those obtained with the remaining methods. How-
ever, TAP613 was also trained on the DS178 testing set
used for the comparisons, as surely were both the CM
and ADM methods (DS178 contains binding affinity data
of poly-Alanine peptides).
To further compare these methods, we have used a ref-
erence set of 723 MHCI-restricted T cell epitopes and
correlated the scores predicted by the different methods
(Table III). Interestingly, TAP613 predictions were signifi-
cantly closer to the predictions by CM (Rs 5 0.86), a
matrix-based method, than to those by TAPRED (0.29)
and SVMTAP (0.76), which are based on SVM. Likewise,
ADM predictions also correlated better with TAP613 pre-
dictions (0.59) than with those by TAPPRED (0.17) and
SVMTAP (0.51). The extreme disparity of TAPPRED pre-
dictions with regard to the remaining methods was
already noted by Zhang et al.25 Overall, these results
support the view that existing SVM-based methods
(TAPPRED and SVM) have suffered to some extent from
data over-fitting, particularly TAPPRED, while we do not
expect such a problem with our TAP613 model, as it was
trained on a much larger dataset.
The TAPREG server
We have implemented a Web tool, TAPREG, for predict-
ing the binding affinity of peptides to TAP, which is avail-
able for free public use at http://imed.med.ucm.es/Tools/
tapreg/ [Fig. 4(A)]. There are two models available at the
TAPREG site that were trained both on the DS613 dataset
using the entire peptide sequences; one was generated from
a sparse representation of peptide sequences and the other
from a blosum representation. The model trained on blo-
sum-encoded sequences displayed a somewhat lower pre-
dictive performance (Rp 5 0.87  0.03) than the sparse
counterpart (Rp 5 0.89  0.03), but nonetheless, it is
included in the TAPREG server because blosum representa-
tion of sequences can often increase the generalization
power of predictive models. The input data for TAPREG
can consist of either protein sequences or multiple peptide
sequences. For the protein sequence, TAPREG returns all
9-mer peptides encompassed by the protein, ranked by
their affinity to TAP (IC50). The number of peptides listed
in the output can also be limited using a user-defined
threshold of binding affinity [Fig. 4(B)]. For the peptide
input, the server returns the affinity of each individual
peptide [Fig. 4(C)]. As TAP can bind and transport pep-
tides of arbitrary length ranging from eight to 16 resi-
dues,14,21 TAPREG will predict the affinity of any peptide
within that length range as described below.
Table II
Correlation Between Experimental TAP Binding Affinities and Predicted
Values Using Different Methods
Method Rs Reference
TAP613 0.89  0.03 This study
SMM 0.87 (0.82) 28
ADM 0.74 (0.72–0.83) 29
TAPPRED 0.67 (0.88) 26
SVMTAP 0.61 (0.82) 27
Rs were computed using a testing set of 178 peptides of known affinity to TAP.
For the TAP613 model, Rs shown in the table is that achieved in cross-validation.
Correlations reported in the literature for the different methods are shown in
parentheses.
Table III
Correlation Between TAP Binding Affinity Predictions by Different
Methods
CM TAP613 TAPPRED ADM SVMTAP
CM 1 0.86 0.26 0.84 0.68
TAP613 0.86 1 0.29 0.59 0.76
ADM 0.84 0.59 0.17 1 0.51
TAPPRED 0.26 0.29 1 0.17 0.34
SVMTAP 0.68 0.76 0.34 0.51 1
Table shows Rs values that were obtained by correlating the TAP binding affinity
scores of 723 MHCI-restricted T cell epitopes predicted with the different
methods.
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In general, models generated using machine-learning
algorithms require input data of the same format as the
data used for training. Therefore, in TAPREG, we have
implemented a system to predict the TAP binding affinity
of any peptide longer than nine residues, for example,
ALRQFDSMERDNAVFL, by applying the model to a
peptide fragment encompassing the first five N-terminal
and last four C-terminal residues of the longer peptide;
in this example, ALRQFAVFL. For peptides of eight resi-
dues, for example AVDFSDRS, we simply insert an Ala-
nine at P6, AVDFSADRS, and then predict the binding
affinity. Note that the P6 residue had the lower contribu-
tion to TAP binding [Fig. 1(A)]. Using the 5N3C model,
which achieved the same correlation as the TAP613 model
that was trained on the entire 9-mer peptides (Fig. 2),
the binding of any peptide longer than eight residues
could be predicted by applying the model to a derivative
fragment consisting of the first 5 N-terminal and last 3-C
terminal residues.
DISCUSSION
The majority of TAP binding models have been
derived from the same dataset consisting of 435 9-mer
peptides of known affinity which was made available by
Dr. Peter van Endert28 (PVE435). In contrast, in this
work, we have used a larger dataset of 613 peptides
(DS613)—encompassing 178 new extra peptides—to
study TAP selectivity quantitatively, using SVM regres-
sion models that were trained on single residue and
residue combinations drawn from the peptides in the
dataset. Thus, we have been able to recognize that each
peptide position has a significant contribution to TAP
binding, and that the contribution of the P4 residue is
equivalent to that of the P3 residue [Fig. 1(A)]. Previ-
ously, only the positions P1, P2, P3, and the C-terminal
end of the peptide were thought to be clearly relevant
for binding to TAP.12,22,26,28,29 We have confirmed
that the C-terminal end of the peptide has the largest
quantitative input to TAP binding; a model trained on
this residue alone reached an Rp 5 0.68  0.06. None-
theless, we have shown that the N-terminal half of the
peptide has a larger contribution to TAP binding than
the C-terminal half of the peptide, as judged by the pre-
dictive performance of SMVs trained on peptide frag-
ments encompassing a varying number of N-terminal
and C-terminal residues of the peptides in the DS613
dataset (Fig. 2).
Figure 4
TAPREG server for predicting peptide binding affinity to TAP. (A) TAPREG Web interface. TAPREG can take two types of input data consisting of
either multiple peptides in FASTA format (size 8 to 16 allowed) or a protein sequence in FASTA format. For protein sequences, TAPREG computes
the TAP affinity of all 9-mer peptides in the protein and returns the peptides sorted by their affinity (IC50) (Panel B). When multiple peptides are
submitted, the program returns the binding affinity to TAP (IC50) of each peptide (Panel C).
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Optimal modeling of the binding affinity of peptides
in the DS613 dataset was achieved by SVM models
trained on the full-length peptide sequences (TAP613) or
on 8-residue fragments consisting of the first five N-ter-
minal and last three C-terminal residues (5N3C) of the
peptides (Rp 5 0.89  0.03) [Figs. 1(B) and 2]. These
results may reflect the observation that TAP can trans-
port peptides of eight and nine residues with comparable
efficiency.14,21 Overall, that optimal fitting of TAP bind-
ing affinity data required training on multiple peptide
residues also implies that all peptide residues—perhaps
with the exception of the P6 residue—have a relevant
contribution to TAP binding.
The correlation between predictions and experimental
binding affinity values achieved by models TAP613 and
5N3C, both trained on the DS613 dataset, is larger (0.89
 0.03) than that reported for any predictive model of
TAP binding affinity.26-29 It is worth noting that, unlike
any of the related studies, we have not only evaluated the
predictive performance of our models in cross-validation
experiments but have also repeated the experiments
10 times and provided confidence values (standard devia-
tions). Moreover, we have also shown that the enhanced
predictive performance obtained with the model trained
on the DS613 dataset is not related to sequence similarity
redundancy (Fig. 3). In fact, we have found that peptides
with high sequence similarity generally differ in their
binding affinity (Fig. 3). Therefore, similar sequences are
not redundant, and instead of inflating prediction rates,
have a genuine contribution to model TAP binding affin-
ity appropriately; hence, the enhanced prediction rates
that we have obtained with the model trained in the
DS613 dataset (Table I).
Using the new 178 peptides of known affinity to TAP
collected in this study as a testing set (DS178 dataset), we
have proved that two previous SVM-based methods
(TAPPRED26 and SMVTAP27) for predicting binding af-
finity of peptides to TAP, which were trained on the
PVE435 dataset, appear to have suffered to some extent
from data overfit; they achieved much lower correlation
coefficients in the testing DS178 dataset than those
reported on the PVE435 dataset (Table II). We have also
evaluated two matrix-based methods, ADM29 and
CM,28 on the same DS178 dataset, and they achieved cor-
relations (0.87 and 0.74, respectively) that were similar to
those originally reported by the authors (Table II). How-
ever, it is likely that these two matrix-based methods
were trained on some of the peptides included in the
DS178 dataset, because they were developed using binding
affinity data of poly-Alanine peptides, such as those
included in the DS178 dataset. In any case, TAP binding
affinity predicted by our SVM models correlated more
closely with those predicted by CM than with those pre-
dicted by related SVM-based methods (Table III). Over-
all, these results highlight the relevance of identifying and
including new data points for training predictive models.
In this study, we have also developed a Web-based
tool, TAPREG, to predict the binding affinity of peptides
to TAP, which is available for free public use at http://
imed.med.ucm.es/Tools/tapreg/. Currently, there are two
dedicated web-based tools to predict the binding affinity
of peptides to TAP: SMVTAP27 (http://www-bs.informatik.
uni-tuebingen.de/Services/SVMTAP/) and TAPPRED26
(http://www.imtech.res.in/raghava/tappred/), both of them
based on SVMs. These two resources use a protein
sequence as input and report the 9-mer peptides encom-
passed by the protein, ranked by their predicted binding
affinity to TAP. In addition to this task, TAPREG can be
used to predict the binding affinity to TAP of multiple
peptides with a length ranging from eight to 16 resi-
dues,14,21 which is consistent with the transport activity
displayed by TAP.
Until now TAP binding affinity of peptides longer than
nine residues could only be achieved using quantitative
matrices, and only the 3 N-terminal residues and the
C-terminus of the peptide were considered to matter for
TAP binding.28 In contrast, in TAPREG, we compute the
TAP affinity using nine residues selected from the larger
peptides—those equivalent to the 9-mer peptides used
for training—as we have shown that all residues in a 9-
mer peptide contribute to binding. To our knowledge,
this is the first machine-learning based approach that can
predict the binding affinity to TAP of peptides longer
than nine residues.
CONCLUSIONS
We have used a large dataset of 9-mer peptides of
known affinity to TAP to dissect the TAP binding prefer-
ences, concluding that each peptide position has a quan-
titative contribution to TAP binding. Moreover, we have
been able to generate SVM models with enhanced predic-
tive performance as a result of including new peptide
binding data. Because accurate modeling of TAP activity
is relevant for T cell epitope selection,12,13 we have
implemented the Web-based tool TAPREG (http://imed.
med.ucm.es/Tools/tapreg/). Unlike any related resource,
TAPREG can be used to predict the binding affinity of
peptides ranging from eight to 16 residues, in a manner
that is consistent with the activity exhibited by TAP.
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